Theodoros Iliakis

415 total citations
17 papers, 97 citations indexed

About

Theodoros Iliakis is a scholar working on Genetics, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Theodoros Iliakis has authored 17 papers receiving a total of 97 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Genetics, 8 papers in Pathology and Forensic Medicine and 5 papers in Oncology. Recurrent topics in Theodoros Iliakis's work include Chronic Lymphocytic Leukemia Research (8 papers), Lymphoma Diagnosis and Treatment (8 papers) and Cutaneous lymphoproliferative disorders research (4 papers). Theodoros Iliakis is often cited by papers focused on Chronic Lymphocytic Leukemia Research (8 papers), Lymphoma Diagnosis and Treatment (8 papers) and Cutaneous lymphoproliferative disorders research (4 papers). Theodoros Iliakis collaborates with scholars based in Greece, Austria and United Kingdom. Theodoros Iliakis's co-authors include Panagiotis Diamantopoulos, Nora‐Athina Viniou, Vasiliki Papadopoulou, Theodoros P. Vassilakopoulos, Marie‐Christine Kyrtsonis, Panayiotis Panayiotidis, Maria K. Angelopoulou, Maria Dimou, Μaria Dalamaga and Pietro Quaglino and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and European Journal of Cancer.

In The Last Decade

Theodoros Iliakis

17 papers receiving 97 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Theodoros Iliakis Greece 5 37 23 23 22 22 17 97
Zaina P. Qureshi United States 4 32 0.9× 32 1.4× 21 0.9× 10 0.5× 9 0.4× 32 95
Kenta Nakama Japan 6 21 0.6× 21 0.9× 9 0.4× 23 1.0× 17 0.8× 12 76
Florentina Delli Greece 8 37 1.0× 20 0.9× 24 1.0× 21 1.0× 98 4.5× 15 176
Francine Foss United States 6 107 2.9× 18 0.8× 71 3.1× 32 1.5× 119 5.4× 13 206
Antonio Sahuquillo‐Torralba Spain 8 27 0.7× 9 0.4× 83 3.6× 33 1.5× 61 2.8× 36 179
Lisa Barbarotta United States 7 9 0.2× 22 1.0× 13 0.6× 73 3.3× 5 0.2× 12 143
Brooke Rothstein United States 5 18 0.5× 7 0.3× 96 4.2× 12 0.5× 81 3.7× 10 189
Eric Hong United States 7 54 1.5× 4 0.2× 46 2.0× 45 2.0× 89 4.0× 9 151
Isabella Del Corso Italy 5 25 0.7× 32 1.4× 58 2.5× 41 1.9× 37 1.7× 7 122
Astrid Irwanto Singapore 7 29 0.8× 8 0.3× 15 0.7× 39 1.8× 6 0.3× 13 130

Countries citing papers authored by Theodoros Iliakis

Since Specialization
Citations

This map shows the geographic impact of Theodoros Iliakis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Theodoros Iliakis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Theodoros Iliakis more than expected).

Fields of papers citing papers by Theodoros Iliakis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Theodoros Iliakis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Theodoros Iliakis. The network helps show where Theodoros Iliakis may publish in the future.

Co-authorship network of co-authors of Theodoros Iliakis

This figure shows the co-authorship network connecting the top 25 collaborators of Theodoros Iliakis. A scholar is included among the top collaborators of Theodoros Iliakis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Theodoros Iliakis. Theodoros Iliakis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Papadavid, Evangelia, Vasiliki Pappa, Vasiliki Nikolaou, et al.. (2021). Multicentric EORTC retrospective study shows efficacy of brentuximab vedotin in patients who have mycosis fungoides and Sézary syndrome with variable CD30 positivity*. British Journal of Dermatology. 185(5). 1035–1044. 16 indexed citations
2.
Dimou, Maria, et al.. (2021). Complete eradication of chronic lymphocytic leukemia with unusual skin involvement of high mitotic index after time‐limited venetoclax/obinutuzumab treatment. SHILAP Revista de lepidopterología. 9(7). e04514–e04514. 2 indexed citations
3.
Marinos, Leonidas, et al.. (2021). New insights into granulomatous mycosis fungoides (GMF): a single-center experience. European Journal of Cancer. 156. S69–S70. 2 indexed citations
4.
Stamouli, Maria, Theodoros Iliakis, Thomas Thomopoulos, et al.. (2021). Allogeneic Stem Cell Transplantation with a Novel Reduced Intensity Conditioning Regimen for the Treatment of Patients with Primary Cutaneous T-cell Lymphomas. SHILAP Revista de lepidopterología. 3(2). 72–72. 3 indexed citations
5.
Nikolaou, Vasiliki, et al.. (2020). Another window into tumor microenvironment: a case of Β‐cell rich folliculotropic mycosis fungoides responding to rituximab. Australasian Journal of Dermatology. 61(2). e226–e228. 2 indexed citations
6.
7.
Dimou, Maria, Theodoros Iliakis, Theodoros P. Vassilakopoulos, et al.. (2019). Safety and efficacy analysis of long-term follow up real-world data with ibrutinib monotherapy in 58 patients with CLL treated in a single-center in Greece. Leukemia & lymphoma. 60(12). 2939–2945. 14 indexed citations
8.
Τζένου, Τατιάνα, Theodoros Iliakis, Efstathios Koulieris, et al.. (2017). Validation of Frailty Assessment in Multiple Myeloma (MM) Patients. Clinical Lymphoma Myeloma & Leukemia. 17(1). e137–e137. 1 indexed citations
9.
Τζένου, Τατιάνα, et al.. (2015). Study of MGUS-Series: Disease Evolution, Coexistant Disorders and Other Clinical Observations. Blood. 126(23). 5323–5323. 1 indexed citations
10.
Diamantopoulos, Panagiotis, et al.. (2015). 5-Azacytidine in the Treatment of Intermediate-2 and High-risk Myelodysplastic Syndromes and Acute Myeloid Leukemia. A Five-year Experience with 44 Consecutive Patients.. PubMed. 35(9). 5141–7. 5 indexed citations
11.
Iliakis, Theodoros, Panagiotis Diamantopoulos, Vasiliki Papadopoulou, et al.. (2014). An Adult Patient with Systemic Mastocytosis and B-Acute Lymphoblastic Leukemia. Case Reports in Medicine. 2014. 1–5. 3 indexed citations
12.
Papageorgiou, Sotirios G., Sotirios Sachanas, Gerassimos A. Pangalis, et al.. (2014). Gastric involvement in patients with primary mediastinal large B-cell lymphoma.. PubMed. 34(11). 6717–23. 4 indexed citations
13.
Diamantopoulos, Panagiotis, et al.. (2014). PARP1-Driven Apoptosis in Chronic Lymphocytic Leukemia. BioMed Research International. 2014. 1–6. 36 indexed citations
14.
Diamantopoulos, Panagiotis, Marina Mantzourani, Nikolaos Spanakis, et al.. (2013). Survivin Messenger RNA Levels in Epstein-Barr Virus–Positive Patients With Leukemic Low-Grade B-Cell Lymphomas Expressing the Latent Membrane Protein 1: Evidence of Apoptotic Function?. Clinical Lymphoma Myeloma & Leukemia. 14(1). 56–60. 2 indexed citations
15.
Iliakis, Theodoros, Vasiliki Papadopoulou, Panagiotis Diamantopoulos, et al.. (2013). Cessation of tyrosine kinase inhibitors in patients with chronic-phase chronic myelogenous leukemia following durable complete molecular response: a single center facing the dilemma.. PubMed. 33(8). 3509–14. 1 indexed citations
16.
Papadopoulou, Vasiliki, Panagiotis Diamantopoulos, Athanasios Galanopoulos, et al.. (2013). Evidence for regulation of oxidative stress by latent membrane protein 1 oncoprotein in patients with low-grade leukemic B cell lymphoma with latent Epstein–Barr virus infection. Leukemia & lymphoma. 55(8). 1904–1909. 2 indexed citations
17.
Diamantopoulos, Panagiotis, Vasiliki Papadopoulou, Fani Kalala, et al.. (2013). Rituximab in the treatment of EBV-positive low grade B-cell lymphoma.. PubMed. 33(12). 5693–8. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zaina P. Qureshi Breakdown of academic impact, for papers by Kenta Nakama Breakdown of academic impact, for papers by Florentina Delli Breakdown of academic impact, for papers by Francine Foss Breakdown of academic impact, for papers by Antonio Sahuquillo‐Torralba Breakdown of academic impact, for papers by Lisa Barbarotta Breakdown of academic impact, for papers by Brooke Rothstein Breakdown of academic impact, for papers by Eric Hong Breakdown of academic impact, for papers by Isabella Del Corso Breakdown of academic impact, for papers by Astrid Irwanto
Rankless by CCL
2026